Acute chest pain (ACP) is a common symptom that often leads to hospital admission. It is a challenge for healthcare professionals due to its broad differential diagnosis, ranging from benign conditions to life-threatening diseases such as acute coronary syndrome (ACS).
Each encounter with a patient presenting ACP should begin with a thorough history and physical examination. The patient's age, sex, risk factors for cardiovascular disease, and the characteristics of the pain should guide the initial assessment. A detailed history can help distinguish cardiac from non-cardiac causes.
Electrocardiogram (ECG) is the first-line diagnostic test in ACP. It can identify ST-segment elevation myocardial infarction (STEMI), which requires immediate reperfusion therapy. In non-diagnostic ECGs, high-sensitivity cardiac troponin (hs-cTn) assays are critical for the early detection of non-ST elevation ACS.
Risk stratification is crucial in ACP. Several risk scores, such as the GRACE and TIMI scores, can predict the likelihood of adverse outcomes in ACS. These scores can guide the decision for invasive management. For low-risk patients, coronary CT angiography can rule out significant coronary artery disease.
Management of ACP depends on the underlying cause. In ACS, early reperfusion therapy in STEMI or optimal medical therapy in non-ST elevation ACS is recommended. Non-cardiac causes of ACP should be managed accordingly. It is essential to reassess the patient's response to treatment and adjust the management plan as necessary.
In conclusion, the approach to ACP involves a systematic evaluation, appropriate diagnostic testing, risk stratification, and tailored management strategies. A high index of suspicion and a comprehensive understanding of the various causes of ACP are crucial for healthcare professionals to provide the best patient care.
1.
When does a melanoma metastasize? Implications for management
2.
Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets
3.
Mammography with AI support is a secure method for detecting breast cancer.
4.
Compared to previous estimates, a greater number of patients participate in cancer treatment trials.
5.
The biology of cancer as well as potential treatment options are examined by experts.
1.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
2.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
3.
Tumor-Associated Stroma Regeneration Models
4.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
5.
Immunotherapy Tolerance in Older Adults With Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation